SAN FRANCISCO, Dec. 17 (UPI) -- A French-led international study suggests acute myeloid leukemia patients treated with Vidaza (azacitidine) have significantly increased overall survival.
A middle-aged leukemia patient has became Chile's first patient to receive stem cells from an umbilical cord in a radical procedure that could cure the disease, health officials here said Thursday.
... extreme fatigue, and asking these patients to exercise doesn't sound like a way to help ... trial to assess the effects on an individualized exercise prescription in acute leukemia patients vs. a group ...
... discovered a better way to distinguish acute leukemia patients who require aggressive treatment to prevent ... therapy, and lead to new targeted therapies for leukemia,” says study leader Dr. Clara D. ...
... stealth populations are impervious to conventional chemotherapy and undaunted by targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that bear ...
... treated with the drug imatinib. This approach provides insights on how to improve the treatment of leukemia patients. Details are published June 20th in the open-access journal PLoS Computational ...
... both kinds of tissue.
Newly diagnosed leukemia patients have their cancer cells tested to see ... interest in coming up with better ways to treat these patients," he said. Cleary's findings indicate GSK3 ...
... by setting this molecule OFF."
When researchers blocked NFκB with drugs in cells from leukemia patients, they found a significant increase in mortality among the abnormal T-cells, suggesting that NF ...
... professor in M. D. Anderson's Department of Leukemia.
Patients start on a 5 mg dose of ... and 38 percent had at least a partial response.
Patients on the trial for at least two months were evaluated ...
A drug once dismissed as ineffective in patients with chronic lymphocytic leukemia has shown promising results in two phase I and II clinical trials, according to new research.
BOSTON (Reuters) - Tell-tale cells may be able to warn people they are at risk of the most common type of leukemia, chronic lymphocytic leukemia, U.S. researchers reported on Wednesday.
HONG KONG (Reuters) - Doctors appear to have safely and successfully treated patients with cancer of the blood and bone marrow with a combination of arsenic and vitamin A, according to long-term study ...
... a method for reliably measuring variations in certain proteins that may make good biomarkers in chronic leukemia patients. The study shows that liquid chromatography-mass spectrometry (LC-MS) can ...
Stem cell transplants improve survival among people with a common form of leukemia, researchers said Tuesday.
... is common in certain brain tumors called gliomas and that another occurred in a second patient with the same type of leukemia. Neither mutation had been previously linked to leukemia.
The fact that ...
